Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Mar 28, 2025; 31(12): 100155
Published online Mar 28, 2025. doi: 10.3748/wjg.v31.i12.100155
Table 4 Risk factors for death at 5-year follow-up, n (%)
All-cause mortality
P value
Multivariate analysis, OR (95%CI)
P value
CCR mortality
P value
Multivariate analysis, OR (95%CI)
P value
Yes
No
Yes
No
Sex
    Male144 (41.5)203 (58.5)0.961 (17.6)286 (82.4)0.7
    Female93 (41.0)134 (59.0)37 (16.3)190 (83.7)
Average age75.366.3< 0.0010.93 (0.91-0.95)< 0.00171.566.3< 0.0010.97 (0.94-0.99)0.05
TNM stage
    I-II125 (35.4)228 (64.6)< 0.0010.38 (0.24-0.61)< 0.00134 (9.6)319 (90.4)< 0.0010.26 (0.15-0.46)< 0.001
    III112 (50.7)109 (49.3)164 (29.0)157 (71.0)1
Location
    Right hemicolon84 (44.7)104 (55.3)0.2529 (15.4)159 (84.6)0.46
    Left hemicolon153 (39.6)233 (60.4)69 (17.9)317 (82.1)
Surgery
    Laparoscopy42 (31.6)91 (68.4)0.010.72 (0.44-1.17)0.1917 (12.8)116 (87.2)0.130.68 (0.36-1.27)0.22
    Laparotomy195 (44.2)246 (55.8)181 (18.4)360 (81.6)1
Perioperative complications
    Yes36 (51.4)34 (48.6)0.071.14 (0.62-2.09)0.6820 (28.6)50 (71.4)0.011.72 (0.91-3.27)0.1
    No201 (39.9)303 (60.1)178 (15.5)426 (84.5)1
Postoperative complications
    Yes113 (51.6)106 (48.4)< 0.0011.41 (0.93-2.14)0.142 (19.2)117 (80.8)0.291.25 (0.72-2.04)0.37
    No124 (34.9)231 (65.1)156 (15.8)299 (84.2)1
Adjuvant chemotherapy
    Yes71 (34.3)136 (65.7)0.011.04 (0.64-1.74)0.8450 (26.9)136 (73.1)0.061.60 (0.95-2.72)0.08
    No166 (45.2)201 (54.8)148 (19.3)201 (80.7)1
Neoadjuvant chemo-radiotherapy
    Yes21 (29.6)50 (70.4)0.031.14 (0.61-2.31)0.6912 (19.4)50 (80.6)0.518
    No216 (42.9)287 (57.1)186 (23.1)287 (76.9)
Adherence to follow-up recommendations
    Yes62 (21.6)225 (78.4)< 0.0010.30 (0.20-0.46)< 0.00132 (12.5)225 (87.5)< 0.0010.35 (0.21-0.59)< 0.001
    No141 (55.7)112 (44.3)165 (36.7)112 (63.3)1